London, United Kingdom
Odin Vision, founded in 2019, is a pioneering company positioned at the intersection of Artificial Intelligence and Health Care. Based in the United Kingdom, the company is focused on enhancing endoscopic procedures to facilitate earlier cancer detection and diagnosis.
With its slogan, "Artificial intelligence software to improve the detection and characterisation of polyps in gastroenterology," Odin Vision leverages AI technologies to significantly improve diagnosis outcomes in gastroenterology, aiming to assist healthcare professionals in identifying and characterizing polyps with greater accuracy. By offering such innovative solutions, the company has the potential to transform standard practices within the medical field, ultimately contributing to saving lives through improved early detection.
Their latest financial milestone includes a Seed Round investment on 01 January 2022, backed by AI Seed. This support underlines investors' confidence in the company's cutting-edge solutions and its growth trajectory in the healthcare sector.
